Keywords: injectafar, gets, fda, non-approvable, letter, swiss, pharmaceutical
Injectafar gets FDA non-approvable letter
Article | 24 March 2008
Swiss pharmaceutical firm Galencia says that the US Food and Drug Administration has issued a non-approvable letter regarding its candidate ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
